SEAK Therapeutics is Drug Discovery in United States that focus on molecule drugs business. Founded in 2018. They cover business area such as operator, next-generation precision cancer treatment drug, advanced drug, pediatric cancer, potential small molecule drug, neurodegenerative disease, researcher, advancement, novel drug, area, unmet medical need.
2018
( 8 years old in 2026 )
Molecule Drugs
-
20 Dudley Street
Suite 900
Memphis, TN 38103
United States
Private
operatornext-generation precision cancer treatment drugadvanced drugpediatric cancerpotential small molecule drugneurodegenerative diseaseresearcheradvancementnovel drugareaunmet medical need
* We use standard office opening hours in near SEAK Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SEAK Therapeutics is Drug Discovery business from United States that founded in 2018 (8 years old in 2026), SEAK Therapeutics business is focusing on Molecule Drugs.
SEAK Therapeutics headquarter office and corporate office address is located in 20 Dudley Street Suite 900 Memphis, TN 38103 United States.
SEAK Therapeutics was founded in United States.
In 2026, SEAK Therapeutics is currently focus on molecule drugs sector.
Above is snippet of Google Trends for "molecule drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SEAK Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
